FibroGen

0 followers


FibroGen, Inc. is a science-based biopharmaceutical company discovering and developing a pipeline of first- in-class therapeutics. The Company is focused on fibrosis and hypoxia-inducible factor (HIF) biology and clinical development to advance innovative medicines for the treatment of anemia, fibro... Read more

Industries

Headquarters

Stage

Employees

Links

Org chart

Enrique Conterno

Collapse
Percy H. Carter
Chief Scientific Officer
Christine L. Chung
SVP, China Operations
Richard Farley
VP, Human Resources
R. Wayne Frost
SVP, Regulatory Affairs
Elias Kouchakji
SVP, Clinical Development, Drug Safety, and Pharmacovigilance
Michael D. Lowenstein
Chief Legal Officer
Michael J. Martinelli
SVP, Technical Development
Leanne C. Price
Chief Intellectual Property Officer
Thane Wettig
Chief Commercial Officer
Juan Graham
Svp, Chief Financial Officer
Kirk Christoffersen
Svp, Chief Business Officer
Simon Miller
Vice President Marketing
John Hunter
Chief Scientific Officer
Tricia Stewart
Chief People Officer
Carol Gaddum
Executive Director, Forecasting, Analytics & New Product Planning
Claudia Witschi
Executive Director, Biologics Drug Product
Claudia Witschi
Executive Director, Biologics Drug Product
Michael Joyce
Associate Director, Biologics Drug Product
Akshaya Patel Pharm.d.
Head Of Field Medical
Dr. Olga V. Gambetti M.D., Ph.D., Drmedsci
Medical Director, Clinical Development
Dr. Swati Gondane M.D.
Senior Medical Director/ Global Patient Safety Lead
Lori S.
Executive Medical Director, Clinical Development
Mona T.
Executive Director, Medical Affairs
Aileen Huang (Cuihua)
Sr. Medical Manager